San Francisco, CA, United States of America

Dana Ault-Riche

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2016-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Dana Ault-Riche

Introduction

Dana Ault-Riche is a prominent inventor based in San Francisco, California. She holds three patents that reflect her significant contributions to the field of biotechnology, particularly in the development of vaccines and peptidic compounds aimed at combating influenza.

Latest Patents

Her latest innovations include a broad-spectrum influenza A neutralizing vaccine and D-peptidic compounds, specifically designed to bind to hemagglutinin target proteins. The patents encompass methods for creating and utilizing these compounds. They also cover hemagglutinin mimics and fragments, providing methodologies for screening GB1 peptidic compounds and employing conjugates of these mimics as effective influenza A vaccines. Notably, her work involves identifying L-peptidic compounds that specifically interact with D-peptidic hemagglutinin target proteins, which can then lead to the production of corresponding D-enantiomers capable of neutralizing influenza virus particles.

Career Highlights

Throughout her career, Dana has made significant strides in pharmaceutical research and development. She has worked with Reflexion Pharmaceuticals, Inc., where her innovative approach to biotechnology flourished. Additionally, her affiliation with the University of Toronto has further cemented her role as a leader in her field.

Collaborations

Dana has collaborated with notable colleagues in her research, including Maruti Uppalapati and Stephen B. H. Kent. These partnerships have proved essential in her pursuit of developing cutting-edge solutions to address influenza and enhance vaccine efficacy.

Conclusion

Dana Ault-Riche stands out as an innovative inventor whose work continues to impact the landscape of vaccine development. Her dedication to creating effective biotechnological solutions showcases the importance of intellectual property in advancing public health initiatives. As she continues her research, Dana remains at the forefront of science, inspiring future innovations in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…